290 related articles for article (PubMed ID: 19664608)
1. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.
Morgan MM; Bobeck EN; Ingram SL
Brain Res; 2009 Oct; 1295():59-66. PubMed ID: 19664608
[TBL] [Abstract][Full Text] [Related]
2. PAG mu opioid receptor activation underlies sex differences in morphine antinociception.
Bernal SA; Morgan MM; Craft RM
Behav Brain Res; 2007 Feb; 177(1):126-33. PubMed ID: 17118467
[TBL] [Abstract][Full Text] [Related]
3. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance.
Morgan MM; Clayton CC; Lane DA
Neuroscience; 2003; 118(1):227-32. PubMed ID: 12676152
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.
Campion KN; Saville KA; Morgan MM
Eur J Neurosci; 2016 Nov; 44(9):2667-2672. PubMed ID: 27564986
[TBL] [Abstract][Full Text] [Related]
5. Differences in antinociceptive signalling mechanisms following morphine and fentanyl microinjections into the rat periaqueductal gray.
Morgan MM; Tran A; Wescom RL; Bobeck EN
Eur J Pain; 2020 Mar; 24(3):617-624. PubMed ID: 31785128
[TBL] [Abstract][Full Text] [Related]
6. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
7. Contribution of dopamine receptors to periaqueductal gray-mediated antinociception.
Meyer PJ; Morgan MM; Kozell LB; Ingram SL
Psychopharmacology (Berl); 2009 Jun; 204(3):531-40. PubMed ID: 19225762
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.
Mehalick ML; Ingram SL; Aicher SA; Morgan MM
J Pain; 2013 Dec; 14(12):1601-10. PubMed ID: 24161274
[TBL] [Abstract][Full Text] [Related]
9. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats.
Tortorici V; Nogueira L; Salas R; Vanegas H
Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592
[TBL] [Abstract][Full Text] [Related]
10. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
[TBL] [Abstract][Full Text] [Related]
11. Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
Wilson AR; Maher L; Morgan MM
Neuropharmacology; 2008 Dec; 55(7):1219-25. PubMed ID: 18723035
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antinociception with repeated microinjections of apomorphine into the periaqueductal gray of male and female rats.
Schoo SM; Bobeck EN; Morgan MM
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):234-240. PubMed ID: 29256893
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive tolerance to morphine from repeated nociceptive testing in the rat.
Lane DA; Morgan MM
Brain Res; 2005 Jun; 1047(1):65-71. PubMed ID: 15878767
[TBL] [Abstract][Full Text] [Related]
14. Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat.
Morgan MM; Clayton CC; Boyer-Quick JS
Pain; 2005 Jan; 113(1-2):91-8. PubMed ID: 15621368
[TBL] [Abstract][Full Text] [Related]
15. Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray.
Meyer PJ; Fossum EN; Ingram SL; Morgan MM
Neuropharmacology; 2007 Jun; 52(8):1580-5. PubMed ID: 17445843
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
Lane DA; Patel PA; Morgan MM
Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
[TBL] [Abstract][Full Text] [Related]
17. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
Haghparast A; Gheitasi IP; Lashgari R
Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
[TBL] [Abstract][Full Text] [Related]
18. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
19. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
20. Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
Morgan MM; Reid RA; Stormann TM; Lautermilch NJ
J Pain; 2014 Nov; 15(11):1102-1109. PubMed ID: 25106089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
